<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:hpo ids='HP_0100580'>Barrett's esophagus</z:hpo> is a metaplastic condition with an unpredictable potential for <z:hpo ids='HP_0002664'>neoplasia</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>Mutations of the <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e>-suppressor gene p53 have been implicated in the evolution of some <z:mp ids='MP_0002038'>carcinomas</z:mp> </plain></SENT>
<SENT sid="2" pm="."><plain>These mutations frequently result in intranuclear protein accumulation, which can be detected immunohistochemically </plain></SENT>
<SENT sid="3" pm="."><plain>This study was undertaken to determine whether p53 immunoreactivity in <z:hpo ids='HP_0100580'>Barrett's esophagus</z:hpo> is a marker of <z:hpo ids='HP_0002664'>neoplasia</z:hpo> and, if so, when it occurs in the <z:mpath ids='MPATH_160'>metaplasia</z:mpath>-<z:mpath ids='MPATH_589'>dysplasia</z:mpath>-<z:mp ids='MP_0002038'>carcinoma</z:mp> sequence </plain></SENT>
<SENT sid="4" pm="."><plain>Twenty-eight esophageal resection specimens were studied </plain></SENT>
<SENT sid="5" pm="."><plain>Barrett's mucosa was present in each specimen, low-grade <z:mpath ids='MPATH_589'>dysplasia</z:mpath> in 27, high-grade <z:mpath ids='MPATH_589'>dysplasia</z:mpath> in 26, intramucosal <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> in 18, and submucosal <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> in 5 </plain></SENT>
<SENT sid="6" pm="."><plain>Immunohistochemical staining with the monoclonal antibody Pab1801 was used to detect the intranuclear protein product of mutated p53 </plain></SENT>
<SENT sid="7" pm="."><plain>No p53 immunoreactivity was seen in specimens of Barrett's mucosa or low-grade <z:mpath ids='MPATH_589'>dysplasia</z:mpath> </plain></SENT>
<SENT sid="8" pm="."><plain>p53 immunoreactivity was found only in specimens of high-grade <z:mpath ids='MPATH_589'>dysplasia</z:mpath>, intramucosal <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e>, and submucosal <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> </plain></SENT>
<SENT sid="9" pm="."><plain>Sixty-nine percent (18/26) of these specimens exhibited mutated p53; 18 of 26 specimens of high-grade <z:mpath ids='MPATH_589'>dysplasia</z:mpath> (69%), 12 of 18 intramucosal <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> specimens (67%), and two of five submucosal <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> specimens (40%) expressed mutated p53 </plain></SENT>
<SENT sid="10" pm="."><plain>When p53 staining was observed, the spectrum of neoplastic changes (high-grade <z:mpath ids='MPATH_589'>dysplasia</z:mpath>, intramucosal <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e>, submucosal <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e>) within the specimen was positive </plain></SENT>
<SENT sid="11" pm="."><plain>We conclude that (1) p53 immunoreactivity in <z:hpo ids='HP_0100580'>Barrett's esophagus</z:hpo> is a frequent, but not inclusive, marker for high-grade <z:mpath ids='MPATH_589'>dysplasia</z:mpath>, intramucosal <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e>, and submucosal <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> and (2) immunoreactivity occurs late in the <z:mpath ids='MPATH_160'>metaplasia</z:mpath>-<z:mpath ids='MPATH_589'>dysplasia</z:mpath>-<z:mp ids='MP_0002038'>carcinoma</z:mp> sequence, during the transition to high-grade <z:mpath ids='MPATH_589'>dysplasia</z:mpath> </plain></SENT>
</text></document>